Skip to content

Bausch Health Companies BHC Additional Paid-In Capital

Additional Paid-In Capital at other companies

PBH
Prestige Consumer HealthcarePBH
$608.52M+2.5%
Bausch + Lomb logo
Bausch + LombBLCO
$8.58B+1.6%
Staar Surgical logo
Staar SurgicalSTAA
$507.92M+6.5%
Ardelyx logo
ArdelyxARDX
$1.13B+5.7%
Organon logo
OrganonOGN
$186M+43.1%
HRO
HarrowHROW
$212.8M-5.7%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.86B-15.9%

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's additional paid-in capital?
Bausch Health Companies (BHC) reported additional paid-in capital of $295M in Q1 2026.
How has Bausch Health Companies's additional paid-in capital changed year-over-year?
Bausch Health Companies's additional paid-in capital increased by 34.1% year-over-year, from $220M to $295M.
What is the long-term trend for Bausch Health Companies's additional paid-in capital?
Over 5 years (2020 to 2025), Bausch Health Companies's additional paid-in capital has grown at a -4.7% compound annual growth rate (CAGR), from $454M to $357M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.